Acutus Medical, Inc.
AFIB
$0.0538
$0.011828.10%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 155.63% | 172.41% | 191.87% | 128.05% | -43.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 155.63% | 172.41% | 191.87% | 128.05% | -43.47% |
| Cost of Revenue | 55.37% | 76.89% | 73.14% | 113.22% | -54.68% |
| Gross Profit | 134.13% | 66.11% | 96.55% | -101.15% | 67.04% |
| SG&A Expenses | -1.53% | -32.16% | -25.38% | 125.51% | -75.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.69% | -0.43% | -7.03% | 114.03% | -71.65% |
| Operating Income | 55.16% | 50.70% | 46.38% | -111.53% | 77.08% |
| Income Before Tax | 57.46% | 91.45% | 51.99% | -102.37% | 90.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.46% | 91.45% | 51.99% | -102.45% | 90.61% |
| Earnings from Discontinued Operations | 57.67% | 96.09% | 103.61% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.64% | 95.02% | 90.07% | -323.49% | 35.19% |
| EBIT | 55.16% | 50.70% | 46.38% | -111.53% | 77.08% |
| EBITDA | 55.27% | 50.86% | 46.96% | -113.20% | 75.90% |
| EPS Basic | 58.39% | 95.13% | 90.37% | -312.53% | 37.20% |
| Normalized Basic EPS | 30.05% | 50.58% | 11.23% | -110.87% | 76.59% |
| EPS Diluted | 58.39% | 95.13% | 90.37% | -232.48% | 37.20% |
| Normalized Diluted EPS | 30.05% | 50.58% | 11.23% | -109.45% | 76.59% |
| Average Basic Shares Outstanding | 1.83% | 2.35% | 3.23% | 2.19% | 3.19% |
| Average Diluted Shares Outstanding | 1.83% | 2.35% | 3.23% | -21.69% | 3.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
